申请人:Pfizer Inc.
公开号:US20030162765A1
公开(公告)日:2003-08-28
This present invention relates to compounds of the formula
1
wherein G, R
1
and R
2
are defined as in the specification, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central nervous system and other disorders.
本发明涉及公式1的化合物,其中G、R1和R2如规范中所定义,以及含有它们的制药组合物,以及它们在治疗和预防中枢神经系统和其他疾病方面的用途。